Synthesis and Pharmacokinetics of Nanosized NH2‑UiO‑66 (Zr) Metal-Organic Frameworks
Синтез и фармакокинетика наноразмерных NH2‑UiO‑66 (Zr) металлоорганических каркасов
2025-12-01
SCID: 54.1/uqeybrpq
Discuss with AI
NH2-UiO-66 (Zr)doxorubicin loadingnanosized metal-organic frameworkspharmacokinetics / prolonged circulationpolyethylene glycol (PEG) surface functionalization
Figures from the paper
Abstract (AI)
Abstract The application of porous nanomaterials in drug delivery offers a promising strategy to mitigate the adverse side effects of chemotherapy. In this study, we report the synthesis of nanosized NH 2 -UiO-66 (Zr) metal-organic frameworks as carriers of doxorubicin. The nanoparticles exhibited high crystallinity with an average size of 44 nm. Surface functionalization with polyethylene glycol (PEG) markedly enhanced their colloidal stability under physiological conditions. Coated NH 2 -UiO-66 (Zr)@PEG particles demonstrated prolonged circulation in the bloodstream and a significant reduction of nonspecific accumulation in organs with high vascularization. Importantly, these particles retained their capacity for doxorubicin loading, highlighting their potential for drug delivery.
Key Findings
1
NH2-UiO-66 (Zr)@PEG particles exhibited prolonged bloodstream circulation and reduced nonspecific accumulation in highly vascularized organs.
2
Nanosized NH2-UiO-66 (Zr) metal-organic framework nanoparticles were synthesized as doxorubicin carriers.
3
PEG surface functionalization markedly enhanced colloidal stability under physiological conditions.
4
PEG-coated particles retained their capacity to load doxorubicin, supporting their potential for drug delivery.
5
The synthesized nanoparticles showed high crystallinity and an average size of 44 nm.
Research Object
Nanosized NH2-UiO-66 (Zr) metal-organic framework nanoparticles (including PEG-coated NH2-UiO-66 (Zr)@PEG) used as doxorubicin carriers
Research Subject
Synthesis, surface PEG functionalization, colloidal stability, doxorubicin loading capacity, and in vivo pharmacokinetics (circulation time and organ biodistribution reduction of nonspecific accumulation) of the nanoparticles
Publication Details
Publication Date
2025-12-01
Journal
Publisher
ISSN
Cited by
2
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest